Lack of tolerance to the treatment, makes the interface choice for non-invasive ventilation (NIV) one of the key factor. To date the helmet is rarely used in Acute Hypercapnic Respiratory Failure (AHRF), because of its large dead space, despite in hypoxic respiratory failure, it is largely employed as a "rotating" strategy when the facial mask is poorly tolerated. In a multicenter randomized controlled trial, the investigators will compare the clinical efficacy of a new helmet designed to specifically improve the performance in chronic obstructive pulmonary disease (COPD) versus a full face mask during an episode of AHRF.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
The helmet is a kind of interface similar to a hood to deliver NIV
The total face mask is the "classical" interface for NIV delivery
Sant'Orsola malpighi Hospital
Bologna, Italy
Sant'Orsola Malpighi
Bologna, Italy
Arterial Blood gases
Time frame: at 1 hour after the start of NIV
Arterial Blood Gases
Time frame: Once a day at 8 am until discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.